Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
M
M
Sarikaya
E
E
Koçak
S
S
Köklü
A
A
Babali
B
B
Cakal
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004279:DNA, Viral / Q000032:analysis; D017809:Fatal Outcome; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D017114:Liver Failure, Acute; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure; D011379:Prognosis
D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; C413685:entecavir; D006147:Guanine